Global Adrenocortical Hormones API Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Cortical Hormone, fully called "Adrenal Cortical Hormone", are a group of steroids secreted by adrenal corticosteroids, mainly including glucocorticoids and salt corticosteroids, as well as a small amount of sex hormones, which are important hormones involved in the metabolism of sugar, fat and protein.
Leading products represented by Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianjin Pharmaceutical Group and Xianju Pharma have occupied a leading position in the international market, and the market share of them is over 40% in the global market. The North American market is the most important consumer region, accounting for about 40% of the global total in 2019.Europe is second only to North America, accounting for less than 30% of the global market. The downstream markets for the use of corticosteroid apis are mainly injectable, oral, topical, and inhaled. Among them, oral drugs accounted for the largest proportion, accounting for nearly 50% of the market in 2019.

In 2020, the global Adrenocortical Hormones API market size was US$ 2107.3 million and is forecast to 3057.6 million US in 2027, growing at a CAGR of 6.4% during the 2021-2027. In this study, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Adrenocortical Hormones API.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Adrenocortical Hormones API market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Adrenocortical Hormones API market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Adrenocortical Hormones API market. Readers of the report can become informed about current and future trends of the global Adrenocortical Hormones API market and how they will impact market growth during the forecast period.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Segment by Type
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others

Segment by Application
Injectable Drugs
Oral Drugs
For External Use Drugs
Inhalation Drugs

By Company
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianjin Pharmaceutical Group Co., Ltd.
Xianju Pharma
Guangdong VTR Bio-Tech Co., Ltd
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical Company Limited
Steroid SpA
Junye Pharmaceutical Co., Ltd.
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical Co., Ltd
Shandong Taihua Bio & Tech Stock Co., Ltd
Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
Teva
Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd
Shandong Sito Bio-technology CO., LTD

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
QYR-18444313

03-Jun-2021

139
License